DAEWON PHARMACEUTICAL revenue breakdown overview

DAEWON PHARMACEUTICAL revenue for the last year amounted to 598.20 B KRW, the most of which — 536.09 B KRW — came from its highest performing source at the moment, Constraints, the year earlier bringing 500.70 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought DAEWON PHARMACEUTICAL 566.57 B KRW, and the year before that — 516.43 B KRW.